Le Lézard
Classified in: Health
Subjects: PDT, PER

HS-UK Appoints a Content Writer to Support the Haag-Streit Academy


HARLOW, England, November 14, 2018 /PRNewswire/ --

Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard optometry and ophthalmic equipment, is pleased to announce the appointment of Lucy Benyon in the role of Content Writer. She will be joining the company's 43-strong team, based in Harlow.

     (Photo: https://mma.prnewswire.com/media/784715/Lucy_Benyon.jpg )

Working with Grant Duncan, HS-UK's Clinical Training Manager, as well as the wider HS-UK team, Lucy will be responsible for creating educational content for the Haag-Streit Academy, which delivers an extensive programme of high-quality training courses to the optical industry.

Lucy joins the company after 22 years in journalism, and has written for a variety of national newspapers and magazines. She has also worked as a health copywriter and health book editor.

Grant Duncan said, "I'm really pleased to welcome Lucy to our expanding clinical training team, responsible for establishing the Haag-Streit Academy. Lucy has a proven track record as a journalist, book editor and content writer and her experience in the health sector will be invaluable in producing and developing high quality educational content for our customers and the wider ophthalmic and optometric communities."

Speaking about her appointment, Lucy said, "I am delighted to be joining HS-UK at such a pivotal time. I really look forward to learning more about the industry, and supporting the Haag-Streit Academy's growth and future success."


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: